The results were consistent with the ELISA results as above-mentioned, confirming that the level of Aβ42Ms at the early stage of AD (3-month-old APP/PS1) was high and the level of Aβ42Os in the late stage of AD (9-month-old APP/PS1) were elevated. This evidence concerns the gene APP and Alzheimer disease.